Prematurity-Related Ventilatory Control (PreVent)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03464396|
Recruitment Status : Recruiting
First Posted : March 14, 2018
Last Update Posted : April 25, 2019
|Condition or disease||Intervention/treatment|
|Respiratory Control in Premature Infants||Other: Bedside Physiology study Other: Carotid Body Function Test Other: Room Air Challenge Other: Hypoxia Challenge Test Other: Effects of Nasal Cannula Flow Diagnostic Test: Magnetic Resonance Imaging Diagnostic Test: Echocardiogram Other: Blood Sample|
The investigator will look at results of breathing tests, non-invasive sound wave (ultrasound) test of the heart and blood vessel (Echocardiography), and a sample of blood to see if it is possible for early detection of breathing control and lung blood vessel dysfunction (pulmonary vascular disease) in infants that are at risk for exposure to long term low oxygen levels. A subset of infants will have a magnetic resonance Imaging study (MRI) between 37- 40 weeks gestational age (GA) or at the time of discharge, whichever comes first.
Respiratory tests include:
- Bedside Physiology Study completed at 28, 32, 36, 40, and 52 weeks gestational age (GA) in conjunction with the respiratory tests. A 90-minute recording will be made using standard recording equipment that includes a conventional pulse oximeter, an EEG, an airflow sampling catheter near the nose, and respiratory inductance plethysmography (RIP) bands. Standard bedside monitoring will continue during the physiologic studies
- Carotid Body Function Test completed at 32, 36, 40 and 52 weeks GA. This test is to unmask respiratory instability in response to hyperoxia.
Challenge Test completed at 36 weeks GA.
- Infants receiving nasal cannula flow with or without supplemental oxygen will undergo a Room Air Challenge Test.
- Infants on RA alone will undergo a Hypoxia Challenge test.
- Effects of Nasal Cannula Flow completed at 28, 32, 36, 40 and 52 week's GA. The flow will be increased through a nasal cannula. This test is to see how flow effects the breathing pattern.
A subset of infants will have an MRI between 37-40 weeks GA or before discharge, whichever comes first. The MRI will allow the doctors to look and see if there is any injury present in the brain that can be linked to an abnormal breathing pattern called periodic breathing.
A subset of infants will have an Echocardiogram (Echo) at 32, 36 and 52 weeks GA. The Echo is performed to assess cardiac structure and function. Echocardiography is performed routinely in premature newborns in the Neonatal Intensive Care Unit (NICU). The echocardiogram will be performed at the infant bedside and will be coordinated with bedside nurse. The infant will remain on a cardio-respiratory monitor during the echocardiogram for approximately 15 minutes.
Infants that have an Echo will have a blood sample collected near the time of the Echo, 3-blood samples total. The purpose of collecting the blood sample is to detect if the Fibroblast Growth Factor (FGF2) level is elevated and possibly be a biomarker of early pulmonary hypertension in pre term infants validated with the echo.
|Study Type :||Observational|
|Estimated Enrollment :||375 participants|
|Official Title:||Physiologic Biomarkers Predicting Ventilatory Instability and Hypoxemia in Pre Mature Infants|
|Actual Study Start Date :||May 14, 2018|
|Estimated Primary Completion Date :||June 1, 2021|
|Estimated Study Completion Date :||June 30, 2021|
Preterm infant study visits
Preterm infants Study Visits
Other: Bedside Physiology study
A 90-minute recording in conjunction with the respiratory evaluations using standard recording equipment that includes a conventional pulse oximeter, an EEG, an airflow sampling catheter near the nose, and respiratory inductance plethysmography (RIP) bands. Standard clinical bedside monitoring will continue during the respiratory evaluations.
Other: Carotid Body Function Test
Infants without nasal cannula will have a nasal cannula placed in their nares. After a 15-minute baseline period and during quiet sleep, the infant will then be exposed to 30 seconds of 100% O2 by increasing FiO2. This test will be repeated 3 times, with at least 3 minutes between tests to allow for return of SpO2 to baseline values. If oxygen saturations increase to 99% for 15 seconds or the infant is apneic for greater than 5 seconds following initiation of 100% O2, the test will be stopped and FiO2 brought back to baseline. Infants in the NICU will be monitored continuously with heart rate, respiratory rate, and SpO2% for 12 hours after Carotid Body Function Test according to NICU standards. Infants discharge who return for Carotid Body Function Test at 40 and 52 weeks PMA will be monitored continuously for 1 hour after the test is finished.
Other: Room Air Challenge
Infants receiving nasal cannula high flow support 3 liters per minute (LPM) or less with or without supplemental O2 at 36 weeks PMA will be eligible. After a 15-minute quiet sleep period, infants' FiO2 will be weaned, in 0.20 decrements for 5 min intervals. Flow then decreased in 10 min intervals, initially in 1 LPM decrement until nasal cannula flow is 1LPM, and then decreased by 50% decrements to 0.125 LPM then off. If the infant is weaned to room air alone for 15 minutes, not meeting failure criteria, he/she has passed the RAC. Failure of the RAC is defined as occurring when SpO2% falls below 80%, even briefly, or remains less than 90% for 5 consecutive minutes any time during the test, bradycardia (HR < 80 bpmx 10 sec) or persistent apnea despite stimulation. Infant is returned to the level of support provided before the RAC begun if meets any failure criteria.
Other Name: RAC
Other: Hypoxia Challenge Test
Infant's breathing room air alone at 36 weeks PMA are eligible. A nasal cannula will be placed prior to a 15-minute period of quiet sleep. During the 15 minutes of quiet sleep, the infant is required to maintain a SpO2 of > 92% in order to undergo the HCT. After the15-minute baseline recording, HCT will begin using FiO2 = 0.18 for 5 minutes. If infant does not meet failure criteria, infant will be given FiO2 0.15 for 10 minutes. Failure criteria is SpO2% < 80% even briefly, or SpO2% 80% to 85% for 30 seconds, bradycardia (HR < 80 bpmx 10 sec) or persistent apnea despite stimulation. If an infant meets criterion for failure, supplemental O2 with FiO2 100% will be started until SpO2% is sustained between 90% and 95%. At that time, the infant will be returned to RA.
Other Name: HCT
Other: Effects of Nasal Cannula Flow
Infants will have a standard nasal catheter in place at time of testing (NeoTech Premature RAM Cannula). A 15-minute baseline recording of all physiologic study parameters prior to initiation. Tested in three groups of infants.
Diagnostic Test: Magnetic Resonance Imaging
A non-sedating MRI scan will be performed on 3 subsets of infants at 37-40 weeks PMA, or when infant is within one week of discharge from the NICU. Standard images as well as research images will be obtained. The research images use the same MRI scanner and collection techniques as standard clinical imaging, but provide a more detailed examination of brain anatomy and injury. Collection of these sequences using our standard non-sedated acquisition practices for infants is well tolerated. Infants will be placed in scanner by registered nurse accompanied by radiology technician to assure infants' comfort during scan. Infant will remain on cardio-respiratory monitor during MRI via a pulse oximetry probe. It will take no longer than one hour to complete MRI scan including transportation to radiology unit.
Other Name: MRI
Diagnostic Test: Echocardiogram
An echocardiogram (referred to as an ultrasound of the heart on the consent form) will be performed to assess cardiac structure and function. Echocardiograms are performed routinely in premature newborns in the NICU. The Echocardiogram will be performed at the infant bedside and will be coordinated with bedside nurse. The infant will remain on a cardio-respiratory monitor during the echocardiogram for approximately 15 minutes.
Other Name: Echo
Other: Blood Sample
Infants that have echocardiograms will have a blood sample collected near the time the echocardiogram is obtained, 3-blood samples total. The blood sample will only be collected with parental permission on an opt-in or out-basis and collected only with routine clinical labs.
- Respiratory phenotype based on physiologic testing [ Time Frame: 36 weeks post menstrual age ]Categorization of subjects based on physiologic Challenge Tests into one of four respiratory phenotypes.
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03464396
|Contact: Julie A Hoffmann, RNfirstname.lastname@example.org|
|Contact: Barbara Warner, MDemail@example.com|
|United States, Missouri|
|Saint Louis, Missouri, United States, 63110|
|Contact: Julie A Hoffmann, RN 314-273-1990 firstname.lastname@example.org|
|Contact: Laura Linneman, RN 314-454-1990 email@example.com|
|Principal Investigator: James Kemp, MD|
|Principal Investigator:||James Kemp, MD||Washington University School of Medicine|